Free Trial

Rayonier (RYN) Competitors

Rayonier logo
$26.42 +0.27 (+1.03%)
(As of 12/20/2024 05:16 PM ET)

RYN vs. OHI, CUBE, RHP, HR, SBRA, GEO, EPR, PCH, NHI, and SHO

Should you be buying Rayonier stock or one of its competitors? The main competitors of Rayonier include Omega Healthcare Investors (OHI), CubeSmart (CUBE), Ryman Hospitality Properties (RHP), Healthcare Realty Trust (HR), Sabra Health Care REIT (SBRA), The GEO Group (GEO), EPR Properties (EPR), PotlatchDeltic (PCH), National Health Investors (NHI), and Sunstone Hotel Investors (SHO). These companies are all part of the "specialized reits" industry.

Rayonier vs.

Omega Healthcare Investors (NYSE:OHI) and Rayonier (NYSE:RYN) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, community ranking, earnings, profitability, dividends, media sentiment and analyst recommendations.

65.3% of Omega Healthcare Investors shares are held by institutional investors. Comparatively, 89.1% of Rayonier shares are held by institutional investors. 1.4% of Omega Healthcare Investors shares are held by insiders. Comparatively, 0.8% of Rayonier shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Omega Healthcare Investors pays an annual dividend of $2.68 per share and has a dividend yield of 7.1%. Rayonier pays an annual dividend of $1.14 per share and has a dividend yield of 4.3%. Omega Healthcare Investors pays out 197.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Rayonier pays out 107.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Omega Healthcare Investors currently has a consensus target price of $40.18, indicating a potential upside of 6.22%. Rayonier has a consensus target price of $33.00, indicating a potential upside of 24.91%. Given Rayonier's higher possible upside, analysts plainly believe Rayonier is more favorable than Omega Healthcare Investors.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Omega Healthcare Investors
0 Sell rating(s)
6 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50
Rayonier
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Omega Healthcare Investors received 144 more outperform votes than Rayonier when rated by MarketBeat users. Likewise, 57.87% of users gave Omega Healthcare Investors an outperform vote while only 54.53% of users gave Rayonier an outperform vote.

CompanyUnderperformOutperform
Omega Healthcare InvestorsOutperform Votes
445
57.87%
Underperform Votes
324
42.13%
RayonierOutperform Votes
301
54.53%
Underperform Votes
251
45.47%

Omega Healthcare Investors has a net margin of 34.41% compared to Rayonier's net margin of 15.84%. Omega Healthcare Investors' return on equity of 8.83% beat Rayonier's return on equity.

Company Net Margins Return on Equity Return on Assets
Omega Healthcare Investors34.41% 8.83% 3.81%
Rayonier 15.84%2.95%1.52%

Omega Healthcare Investors has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500. Comparatively, Rayonier has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500.

In the previous week, Rayonier had 2 more articles in the media than Omega Healthcare Investors. MarketBeat recorded 7 mentions for Rayonier and 5 mentions for Omega Healthcare Investors. Omega Healthcare Investors' average media sentiment score of 1.17 beat Rayonier's score of 0.80 indicating that Omega Healthcare Investors is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Omega Healthcare Investors
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Rayonier
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Omega Healthcare Investors has higher revenue and earnings than Rayonier. Rayonier is trading at a lower price-to-earnings ratio than Omega Healthcare Investors, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Omega Healthcare Investors$1.01B10.10$242.18M$1.3627.82
Rayonier$1.00B3.92$173.49M$1.0624.92

Summary

Omega Healthcare Investors beats Rayonier on 15 of the 20 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RYN vs. The Competition

MetricRayonierReal estate investment trusts IndustryConstruction SectorNYSE Exchange
Market Cap$3.94B$6.96B$8.74B$19.18B
Dividend Yield3.99%6.79%1.87%3.58%
P/E Ratio24.9242.5327.6641.22
Price / Sales3.927.822.2717.58
Price / Cash20.1917.7922.2221.28
Price / Book2.092.546.185.32
Net Income$173.49M$146.30M$516.58M$989.67M
7 Day Performance-8.36%-3.82%-4.46%-3.45%
1 Month Performance-12.75%-4.28%-4.94%-3.73%
1 Year Performance-19.33%1.86%36.24%12.06%

Rayonier Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RYN
Rayonier
4.0028 of 5 stars
$26.42
+1.0%
$33.00
+24.9%
-18.8%$3.94B$1.00B24.92420Ex-Dividend
High Trading Volume
OHI
Omega Healthcare Investors
4.3784 of 5 stars
$39.44
+0.6%
$40.18
+1.9%
+23.0%$10.65B$949.74M28.8950Positive News
CUBE
CubeSmart
3.6574 of 5 stars
$46.53
+0.6%
$51.36
+10.4%
-5.4%$10.52B$1.05B26.143,040Dividend Increase
RHP
Ryman Hospitality Properties
3.9929 of 5 stars
$111.61
-1.4%
$128.57
+15.2%
-1.4%$6.69B$2.32B20.111,471
HR
Healthcare Realty Trust
3.0077 of 5 stars
$17.48
+1.5%
$17.17
-1.8%
-1.4%$6.19B$1.29B-11.01580Analyst Downgrade
Insider Trade
News Coverage
Positive News
SBRA
Sabra Health Care REIT
1.777 of 5 stars
$17.53
+0.2%
$19.14
+9.2%
+18.5%$4.15B$647.51M42.6840Positive News
GEO
The GEO Group
2.2262 of 5 stars
$28.00
+2.2%
$33.50
+19.6%
+159.0%$3.92B$2.41B94.5216,400Analyst Forecast
Positive News
EPR
EPR Properties
3.7325 of 5 stars
$45.31
+0.4%
$48.28
+6.5%
-8.9%$3.43B$636.87M19.5060
PCH
PotlatchDeltic
4.3541 of 5 stars
$42.52
+0.6%
$49.25
+15.8%
-21.2%$3.35B$1.02B203.381,384Positive News
NHI
National Health Investors
3.4438 of 5 stars
$72.75
0.0%
$76.33
+4.9%
+22.6%$3.30B$319.83M25.0020Positive News
SHO
Sunstone Hotel Investors
2.4361 of 5 stars
$12.36
+1.2%
$12.20
-1.3%
+11.7%$2.48B$986.48M16.0740Positive News

Related Companies and Tools


This page (NYSE:RYN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners